MAPT and tauopathy: We recently demonstrated that tau depositions in a tauopathy model mouse can be visualized with tau PET tracers on a scale of subcellular to whole brain by bimodal two‐photon microscope and PET imaging, providing important insight into the sensitivity and disposition of these unique compounds (Tagai et al, 2021).